entertainment -WSS

entertainment

author：fashion 2025-08-12 06:44:04 - browse：5664

Colorful one hundred dollar bills -- health tech coverage from STAT — Adobe

Hospitals aren’t usually in the business of selling technology tools. But that’s changing thanks to a collision of financial pressures and an explosion of new technology that could both improve patients’ health and ease the burden of administrative tasks on limited staff.

At the J.P. Morgan Healthcare conference, an exclusive, invitation-only event for investors, several influential health systems like Mayo Clinic and Mass General Brigham doubled down on new revenue streams including advising companies building artificial intelligence tools or licensing out custom built products as they brace for a tough 2024.

Selling tech isn’t entirely new: a subset of hospitals and academic centers have been licensing out risk models and health record tools for decades. But now, a “perfect storm” of shrinking profit margins and philanthropic dollars, workforce shortages and rising labor costs is driving more hospitals to explore selling new technology they have built, like scheduling or clinical note summary tools, more than they have before, according to Dana Rollison, chief data officer at Moffitt Cancer Center.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： STAT Readout Newsletter: Biotech news today

hotspot

WSS

How AI can help patients find reliable information about doctors

Roche acquires Telavant from Roivant, adding experimental IBD treatment

Roche drug slashes death risk in early

An exit interview with Bristol Myers Squibb CEO Giovanni Caforio

STAT Summit: How researchers deal with rejection

Cassava Sciences’ Alzheimer’s clinical trials should be halted

knowledge

entertainment

explore

Virginia high school admissions case could be legal follow

Health tech investors get more selective as pandemic boom fades

Affirmative action in medical school literally saved lives

FDA approves Eli Lilly ulcerative colitis treatment Omvoh

At least 13 dead in Texas as scorching temps continue

Roivant's CEO is a star, but biotech's black hole persists

Dobbs anniversary: the lost opportunity of abortion as health care

UnitedHealth, Optum discontinue NaviHealth name

Tori Bowie and the unacceptable rates of Black maternal death

Health tech investors get more selective as pandemic boom fades

focus

Merck, Daiichi strike cancer drug pact worth up to $22 billion

Senate panel to vote on hospitals, PBMs, prisoner care

Eli Lilly to pay $200M for Beam’s stake in gene

The FDA weighs the risks of candy

STAT Readout Newsletter: Biotech news today

WHO may add ‘noma' to its list of neglected tropical diseases

hotspot

hotspot

hotspot

leisure time